Guanfacine 72888-0226-05
- Manufacturer
- Advagen Pharma Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 15, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA219689
Need to source Guanfacine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guanfacine Hydrochloride | 3 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Selected Package
72888-0226-05Selected500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-05)
Other packages for this product(3)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-00)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-01)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72888-226-30)